Sucampo Pharmaceuticals Announces One-to-One Conversion of Class B Common Stock into Class A Common Stock

Sucampo Pharmaceuticals, Inc. SCMP (“Sucampo”) today announced that its majority shareholder and only holder of its class B common stock, S&R Technology Holdings, LLC (S&R), has converted all of its shares of Sucampo's class B common stock into shares of its class A common stock. S&R is owned by Ryuji Ueno, M.D., Ph.D., Ph.D., Sucampo's Chairman and CEO, and his wife, Sachiko Kuno, Ph.D., Sucampo's Executive Advisor, International Business Development and a member of Sucampo's Board of Directors. Drs. Ueno and Kuno are the co-founders of Sucampo. Prior to the conversion, there were two classes of common stock authorized, issued and outstanding: class B common stock and See full press release
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsGuidanceGlobal
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!